Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.
This review considers the five major principles governing optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis: off the entry of passage of antibiotics into CSF, (2) the antimicrobial activity of beta-lactams within the purulent CSF in vivo, (3) the bactericidal activity within the CSF, (4) the route and mode of drug administration together with the postantibiotic effect, and (5) the duration of therapy. Special attention is paid to the third principle, bactericidal activity within the CSF, employing the model of the newer, third-generation cephalosporins used in the treatment of meningitis caused by gram-negative aerobic bacilli.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D001693:Biological Transport, Active; D001812:Blood-Brain Barrier; D002511:Cephalosporins / Q000008:administration & dosage; D004357:Drug Synergism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D007477:Ions; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008583:Meningitis, Haemophilus / Q000134:cerebrospinal fluid / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid / Q000188:drug therapy; D008970:Molecular Weight; D010400:Penicillin G / Q000008:administration & dosage; D011485:Protein Binding; D012995:Solubility; D013997:Time Factors
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D007477:Ions; D010400:Penicillin G